Published in Nat Rev Nephrol on June 22, 2010
Relationship between total testosterone, cognitive function, depressive behavior, and sleep quality in chronic kidney disease patients not on dialysis. Clin Exp Nephrol (2012) 0.80
Attention deficit hyperactivity disorder in children with early stages of chronic kidney disease. Med J Islam Repub Iran (2015) 0.78
Should an elderly patient with stage V CKD and dementia be started on dialysis? Clin J Am Soc Nephrol (2013) 0.78
Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis (2016) 0.77
Attention-deficit/hyperactivity disorder in children undergoing peritoneal dialysis. Nephrourol Mon (2015) 0.77
Obsessive Compulsive Inventory-Child Version (OCV-CI) to Evaluate Obsessive Compulsive Disorder in Children With Early Stages of Chronic Kidney Disease: A Case Control Study. Nephrourol Mon (2016) 0.75
Captain Lord's uremia. Turk J Urol (2013) 0.75
[Evaluation and analysis of insomnia in chronic hemodialysis]. Pan Afr Med J (2014) 0.75
Methylglyoxal (MG) and cerebro-renal interaction: does long-term orally administered MG cause cognitive impairment in normal Sprague-Dawley rats? Toxins (Basel) (2014) 0.75
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med (2006) 17.55
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med (2006) 10.65
Delirium in older persons. N Engl J Med (2006) 9.70
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry (2009) 8.74
Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A (2000) 5.20
Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med (2001) 4.85
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet (2006) 4.26
Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science (2004) 4.09
Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87
Cognitive impairment in hemodialysis patients is common. Neurology (2006) 3.68
Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int (2008) 3.34
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14
Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int (2006) 2.85
Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol (2004) 2.82
Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med (2007) 2.71
Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int (2003) 2.65
Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int (2000) 2.51
Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35
Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int (2009) 2.30
Kidney function is associated with the rate of cognitive decline in the elderly. Neurology (2009) 2.27
Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int (2002) 2.24
Incidence of suicide in persons with cancer. J Clin Oncol (2008) 2.21
Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis (2009) 2.18
Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis (2005) 2.16
Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int (2009) 2.10
Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis (1999) 2.03
Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol (2007) 2.01
Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis (2008) 1.98
Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis (2005) 1.91
Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis (2008) 1.91
The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis (2003) 1.90
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A (2003) 1.88
High prevalence of leukoaraiosis in cerebral magnetic resonance images of patients on peritoneal dialysis. Am J Kidney Dis (2007) 1.88
Prevalence of major depressive episode in CKD. Am J Kidney Dis (2009) 1.79
Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study. Arch Neurol (2008) 1.74
The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int (2006) 1.73
Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant (2009) 1.71
Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis (2005) 1.68
Anaemia increases the risk of dementia in cognitively intact elderly. Neurobiol Aging (2006) 1.65
Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int (2008) 1.64
Suicide among US veterans: A prospective study of 500,000 middle-aged and elderly men. Am J Epidemiol (2009) 1.56
CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55
The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant (2008) 1.46
Validation of depression screening scales in patients with CKD. Am J Kidney Dis (2009) 1.43
Opioids in renal failure and dialysis patients. J Pain Symptom Manage (2004) 1.39
Dementia as a predictor of mortality in dialysis patients. Clin J Am Soc Nephrol (2006) 1.36
Risk of Alzheimer's disease among elderly patients with anemia: population-based investigations in Olmsted County, Minnesota. Ann Epidemiol (1997) 1.28
Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? Kidney Int Suppl (2002) 1.20
Cerebrovascular effects of hemodialysis in chronic kidney disease. J Cereb Blood Flow Metab (2007) 1.17
Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis (2003) 1.17
Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures. Am J Kidney Dis (2007) 1.12
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis (2003) 1.12
Renal failure is a risk factor for cefepime-induced encephalopathy. J Nephrol (2008) 1.10
Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit. Brain Res (2009) 1.09
The identification and treatment of depression in patients maintained on dialysis. Semin Dial (2005) 1.09
Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis (2003) 1.09
Valacyclovir neurotoxicity: clinical experience and review of the literature. Eur J Neurol (2009) 1.08
Predictors of in-hospital mortality among older patients. Clinics (Sao Paulo) (2009) 1.07
Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Ann Pharmacother (2008) 1.07
Suicide in the United States end-stage renal disease program. J Am Soc Nephrol (2005) 1.05
Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes. J Clin Invest (1975) 1.04
Brain protection by erythropoietin: a manifold task. Physiology (Bethesda) (2008) 1.03
A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging. AJNR Am J Neuroradiol (2007) 1.02
Opioid metabolites. J Pain Symptom Manage (2005) 1.01
Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function. Gen Hosp Psychiatry (1996) 1.01
Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis (2001) 1.01
Central nervous system manifestations of hyperparathyroidism. Am J Med (1978) 0.97
Delirium in the elderly: a clinical review. Postgrad Med J (2009) 0.97
Electrophysiological and neurobehavioral responses to therapy: the National Cooperative Dialysis Study. Kidney Int Suppl (1983) 0.94
Dialysis disequilibrium syndrome: a narrative review. Semin Dial (2008) 0.94
Opioids and renal function. J Pain (2004) 0.93
Effects of haemodialysis and continuous ambulatory peritoneal dialysis on P300 cognitive potentials in uraemic patients. Ups J Med Sci (2004) 0.91
Effect of short daily home haemodialysis on quality of life, cognitive functioning and the electroencephalogram. Nephrol Dial Transplant (2006) 0.89
Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology (2005) 0.87
Effects of epoetin alfa on the central nervous system. Semin Oncol (2001) 0.87
How can delirium best be prevented and managed in older patients in hospital? CMAJ (2009) 0.86
Differential impairment of psychomotor efficiency and processing speed in patients with chronic kidney disease. Int Urol Nephrol (2008) 0.86
Better preservation of cognitive faculty in continuous ambulatory peritoneal dialysis. Perit Dial Int (1993) 0.84
The relationship between the abnormalities in electroencephalogram and blood levels of parathyroid hormone in dialysis patients. J Clin Endocrinol Metab (1980) 0.84
Dialysis disequilibrium syndrome. Nephrol Nurs J (2001) 0.83
Acyclovir kinetics in end-stage renal disease. Clin Pharmacol Ther (1982) 0.83
Gabapentin toxicity: an important cause of altered consciousness in patients with uraemia. Emerg Med J (2008) 0.83
Effect of high-flux hemodialysis on quality of life and neuropsychological function in chronic hemodialysis patients. Am J Nephrol (1992) 0.82
Depression as a mortality risk factor in hemodialysis patients. Int J Artif Organs (1992) 0.82
Aciclovir and valaciclovir neurotoxicity in patients with renal failure. Nephrol Dial Transplant (2003) 0.82
Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism. Surgery (2008) 0.81
Depression and nonadherence are closely related in dialysis patients. Kidney Int (2009) 0.80
Morphine toxicity in renal failure. J Opioid Manag (2007) 0.76
Recombinant erythropoietin improves cognitive function in chronic haemodialysis patients. Nephrol Dial Transplant (1992) 0.76
Parathyroid hormone, uremia, and the nervous system. Contrib Nephrol (1980) 0.76
Effects of acute renal failure and ganciclovir on the pharmacodynamics of levofloxacin-induced seizures in rats. Biol Pharm Bull (2007) 0.76
Quality improvement through the introduction of interdisciplinary geriatric hemodialysis rehabilitation care. Am J Kidney Dis (2007) 1.73
The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol (2012) 1.48
Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol (2009) 1.43
Falls and fall-related injuries in older dialysis patients. Clin J Am Soc Nephrol (2006) 1.34
Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int (2005) 1.31
Impact of age on peritonitis risk in peritoneal dialysis patients: an era effect. Clin J Am Soc Nephrol (2008) 1.13
Epidemiology and demographic aspects of treated end-stage renal disease in the elderly. Semin Dial (2002) 1.07
Using an electronic self-management tool to support patients with chronic kidney disease (CKD): a CKD clinic self-care model. Semin Dial (2013) 1.01
Necrotizing glomerulonephritis caused by Bartonella henselae endocarditis. Am J Kidney Dis (2004) 0.92
Chiropody may prevent amputations in diabetic patients on peritoneal dialysis. Perit Dial Int (2003) 0.92
Microbiology of peritonitis in peritoneal dialysis patients with multiple episodes. Perit Dial Int (2012) 0.91
A prospective pilot study to measure changes in functional status associated with hospitalization in elderly dialysis-dependent patients. Am J Kidney Dis (2008) 0.89
Acinetobacter peritoneal dialysis peritonitis: description and relation to the SPICE family of organisms. Perit Dial Int (2008) 0.88
Quality of life and rehabilitation of elderly dialysis patients. Semin Dial (2002) 0.86
A qualitative systematic review of the literature supporting a causal relationship between exit-site infection and subsequent peritonitis in patients with end-stage renal disease treated with peritoneal dialysis. Perit Dial Int (2013) 0.86
Relationship between double-cuff versus single-cuff peritoneal dialysis catheters and risk of peritonitis. Nephrol Dial Transplant (2010) 0.85
Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol Dial Transplant (2004) 0.84
Visual impairment in elderly patients receiving long-term hemodialysis. Am J Kidney Dis (2008) 0.82
Causes of death in older peritoneal dialysis patients--can we depend on registry reports? Int Urol Nephrol (2007) 0.81
Improvement in uremic symptoms after increasing daily dialysate volume in patients on chronic peritoneal dialysis with declining renal function. Int Urol Nephrol (2004) 0.80
Peritoneal dialysis after nonrenal solid organ transplantation: clinical outcomes and practical considerations. Perit Dial Int (2010) 0.80
Clinical outcomes after failed renal transplantation-does dialysis modality matter? Semin Dial (2008) 0.80
The concept of frailty in geriatric chronic kidney disease (CKD) patients. Blood Purif (2015) 0.77
Renal transplantation in seniors - a review. Saudi J Kidney Dis Transpl (2008) 0.77
A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE. Int Urol Nephrol (2013) 0.77
Gynecological surgery: not a contraindication for continuation of CAPD. Perit Dial Int (2003) 0.75
Routine use of an abbreviated 4-item scale to assess dependence in essential activities of daily living amongst elderly hemodialysis patients: a validation study. Int Urol Nephrol (2013) 0.75
Development, validation, and implementation of a medication adherence survey to seek a better understanding of the hemodialysis patient. Clin Nephrol (2016) 0.75